Language Select
Logótipo Varian

Press Releases

Março 25, 2019
Varian (NYSE: VAR) today announced it again received the "Best After-Sales Service Award for Radiotherapy Products" in the 2018 Chinese Medical Devices Industry Data and After-Sales Service... Read more
Março 21, 2019
Building on its market-leading efforts in preclinical research aimed at clinical implementation of Flash therapy, Varian (NYSE: VAR) hosted the first meeting of the FlashForward™ Consortium in... Read more
Março 11, 2019
Varian (NYSE: VAR) today announced its second quarter fiscal year 2019 earnings release date and upcoming investor event. Second Quarter Fiscal Year 2019 Earnings The Company will report results... Read more
Março 11, 2019
With an estimated 1.8 million new cancer cases a year in India expected by 20251, Tata Trusts and Varian (NYSE: VAR) announced the signing of a framework agreement intended to increase patient... Read more
Fevereiro 28, 2019
In a ceremony officiated by the Regional Council of Central Denmark Region, Anders Kühnau, and attended by both the Danish Prime Minister Lars Løkke Rasmussen, and the Chairman of the A.P.... Read more
Fevereiro 25, 2019
At a ceremony in Idi-Araba, Lagos, Nigeria, Varian (NYSE: VAR) joined H.E. President Muhammadu Buhari, President of the Federal Republic of Nigeria, and other dignitaries to commission the... Read more
Fevereiro 25, 2019
Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute, a Proton International facility, has joined the FlashForward™ Consortium. Now including 14 members, the consortium... Read more
Fevereiro 06, 2019
Varian (NYSE: VAR) today announced its Eclipse™ treatment planning system and TrueBeam® treatment system have been named Category Leaders in the 2019 Best in KLAS: Software and Services Report... Read more
Fevereiro 05, 2019
Varian (NYSE: VAR) today announced it will be demonstrating a portfolio of smarter cancer care software solutions, February 12-14 in Orlando, FL at HIMSS19, booth 6143. Envisioning a world without... Read more
Janeiro 23, 2019
First Quarter 2019 Summary – Oncology gross orders grew 16% in dollars, or 17% in constant currency – Total company revenues grew 9% in dollars, or 10% in constant currency, to $741 million... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com